Monod Bio

Computational drug discovery platform

This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.

Profluent Bio

Profluent Bio develops generative artificial intelligence models to design novel functional proteins for biopharmaceutical companies and industrial partners.

Medium Biosciences

This company develops AI-designed protein affinity reagents for research teams and diagnostic developers to support target binding and detection.

MendelFOLD

This company develops computational protein modelling tools to help pharmaceutical teams and researchers identify drug binding sites and design new medical treatments.

Open Protein

This company provides a no-code machine learning platform for protein engineering and sequence generation to researchers in biotechnology, pharmaceuticals and academia.

Diffuse Bio

This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.

SynsoryBio

SynsoryBio develops protein therapeutics designed to sense specific disease markers and activate only at targeted tissues to treat cancer and autoimmune disorders.

Aperiam Bio

The company uses computer vision to design stable, high-performing proteins for customers in the cosmetics, therapeutics, and technical reagents sectors.